| Jessica L Brown, PHD | |
|
10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810-1686 | |
| (225) 769-2200 | |
| (225) 768-2185 |
| Full Name | Jessica L Brown |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 23 Years |
| Location | 10101 Park Rowe Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437418209 | NPI | - | NPPES |
| 2197738 | Medicaid | LA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neuromedical Center | 6103716477 | 86 |
News Archive
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies
MILabs will provide an advanced U-SPECT4CT system to the Yale Translational Research Imaging Center (Y-TRIC) in New Haven-Connecticut, with support of an NIH Shared Instrument Grant for advancing their program in multimodality molecular and translational cardiovascular imaging research.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Galectin Therapeutics Inc. today announced that it has entered into a research collaboration with Dr. Jose Jalife of the University of Michigan Medical School to better understand the relationship of Galectin-3 to cardiac fibrosis in chronic cardiac arrhythmias.
Researchers have found that drinking adequate amount of water daily can lower the risk of symptoms of a progressive neurodegenerative disease like Parkinson's.
› Verified 5 days ago
| Entity Name | Neuromedical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216399 PECOS PAC ID: 6103716477 Enrollment ID: O20040318001606 |
News Archive
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies
MILabs will provide an advanced U-SPECT4CT system to the Yale Translational Research Imaging Center (Y-TRIC) in New Haven-Connecticut, with support of an NIH Shared Instrument Grant for advancing their program in multimodality molecular and translational cardiovascular imaging research.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Galectin Therapeutics Inc. today announced that it has entered into a research collaboration with Dr. Jose Jalife of the University of Michigan Medical School to better understand the relationship of Galectin-3 to cardiac fibrosis in chronic cardiac arrhythmias.
Researchers have found that drinking adequate amount of water daily can lower the risk of symptoms of a progressive neurodegenerative disease like Parkinson's.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica L Brown, PHD Po Box 98509, Baton Rouge, LA 70884-9509 Ph: (225) 769-2200 | Jessica L Brown, PHD 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810-1686 Ph: (225) 769-2200 |
News Archive
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies
MILabs will provide an advanced U-SPECT4CT system to the Yale Translational Research Imaging Center (Y-TRIC) in New Haven-Connecticut, with support of an NIH Shared Instrument Grant for advancing their program in multimodality molecular and translational cardiovascular imaging research.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Galectin Therapeutics Inc. today announced that it has entered into a research collaboration with Dr. Jose Jalife of the University of Michigan Medical School to better understand the relationship of Galectin-3 to cardiac fibrosis in chronic cardiac arrhythmias.
Researchers have found that drinking adequate amount of water daily can lower the risk of symptoms of a progressive neurodegenerative disease like Parkinson's.
› Verified 5 days ago
Dr. Franziska Noacklesage, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7784 Innovation Park Dr, Baton Rouge, LA 70820 Phone: 225-343-4232 Fax: 225-343-4233 | |
Dr. Raymond Tucker, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-6565 | |
Paula J Varnado-sullivan, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 740 Colonial Dr, Baton Rouge, LA 70806 Phone: 225-216-9422 Fax: 225-216-1260 | |
Mary Lou Kelley, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7936 Wrenwood Blvd Ste B, Baton Rouge, LA 70809 Phone: 225-925-2036 | |
Dr. Adam Robert Reinwald, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7850 Anselmo Ln, Baton Rouge, LA 70810 Phone: 985-276-8863 | |
Dr. Rachel Renee Stokes, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2333 Government St, Baton Rouge, LA 70806 Phone: 225-383-3414 | |
Dr. Alyson Powell Mccain, PHD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10211 Siegen Lane, Ste 2b, Baton Rouge, LA 70810 Phone: 225-767-3121 Fax: 225-767-3122 |